Work

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis

Year: 2025

Type: article

Abstract: INTRODUC TI ONMemantine is an N-methyl-D-aspartate (NMDA) receptor antagonist primarily United States Food and Drug Administrationapproved for the treatment of moderate-severe Alzheimer's disease.Emerging evidence suggests its potential utility in migraine

Source: Headache The Journal of Head and Face Pain

DOI: 10.1111/head.14979

Authors: M. Ismail K. Yousaf, Francis D. Hussey, Sara Pavitt, Samantha Irwin

Institutions: Virginia Tech, The University of Texas at Austin

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,150